United European Gastroenterology Journal

Papers
(The H4-Index of United European Gastroenterology Journal is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
175
Table of Contents164
UEG Week 2023 Oral Presentations131
Medical guidelines must not be influenced by commercial interests108
Correction to “Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility”96
The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers93
MRI Volumetric Changes in Perianal Fistulizing Crohn's Disease: Moving Toward a Novel Outcome Measure for Therapeutic Response70
Stunned by a stone—A curious case of belly trouble62
UEG's prospects for the future62
Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study54
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management50
Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in Europ48
Shedding a new light on gastric cancer screening48
Artificial intelligence: The researcher's assistant or sheep in wolf's clothing?47
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study45
Letter of Thanks for UEG Week 2022 Reviewers44
Gallbladder polyps growth rate is an independent risk factor for neoplastic polyps43
Sex‐ and Age‐Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post‐Analysis of the COLONPREV Study41
Corticosteroid Use in Childhood‐Onset Inflammatory Bowel Disease: A Nationwide Cohort Study (2006–2022)40
Recent developments in the management of ascites in cirrhosis39
Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 201838
Global Inflammatory Bowel Disease: Opportunities and Challenges for a New Era36
Nodular Regenerative Hyperplasia: Report of 82 Patients and Systematic Review of Literature36
Upcoming Treatments in Celiac Disease: From Luminal Enzymes to Oral Immune Tolerance35
From Postoperative Prognosis to Preoperative Decision‐Making in IPMN35
Dietary Sugar and Sweetened Beverage Intake Increases Inflammatory Bowel Disease Risk: A Systematic Review and Meta‐Analysis35
 34
Issue Information34
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study34
Correction to “A portrait of Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound training programs in Europe: Current practices and opportunities for improvement”33
Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study32
32
0.15535879135132